Northern Trust
ZBIO icon

Northern Trust’s Zenas BioPharma ZBIO Stock Holding History

Northern Trust’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.14M Buy
281,140
+86,500
+44% +$1.72M ﹤0.01% 2408
2026
Q1 		$3.81M Buy
194,640
+39,274
+25% +$882K ﹤0.01% 2614
2025
Q4 		$5.64M Buy
155,366
+22,088
+17% +$726K ﹤0.01% 2404
2025
Q3 		$2.96M Buy
133,278
+13,763
+12% +$224K ﹤0.01% 2816
2025
Q2 		$1.16M Sell
119,515
-723
-0.6% -$7.04K ﹤0.01% 3303
2025
Q1 		$950K Sell
120,238
-4,008
-3% -$31.4K ﹤0.01% 3307
2024
Q4 		$1.02M Buy
+124,246
New +$1.94M ﹤0.01% 3384

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $242M AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Northern Trust's ZBIO Position: Q2 2026 in Review

Northern Trust increased its Zenas BioPharma (ZBIO) stake by 44% in Q2 2026, buying an estimated $1.72M and bringing the position to 281,140 shares worth $7.14M. The position accounts for ﹤0.01% of the portfolio, ranked #2408.

Northern Trust first reported a position in ZBIO in Q4 2024 and has held it in 7 quarters since. 144 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

  • Northern Trust held 281,140 shares of Zenas BioPharma worth $7.14M as of Q2 2026.
  • Northern Trust bought 86,500 Zenas BioPharma shares in Q2 2026, an estimated $1.72M.
  • Zenas BioPharma made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2408 holding.
  • Northern Trust first reported a position in Zenas BioPharma in Q4 2024 and has held it in 7 quarters since.
  • 144 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.